Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 4,257 | 2,983 | 3,240 | 2,320 | 2,569 |
| Gross Profit | 4,160 | 2,980 | 3,240 | 2,320 | 2,630 |
| Operating Expenses | 6,500 | 5,320 | 5,140 | 4,080 | 3,500 |
| Operating Income | -2,243 | -2,337 | -1,900 | -1,760 | -931 |
| Other Income | -177 | -233 | -30 | 90 | -1,519 |
| Pre-tax Income | -2,420 | -2,570 | -1,930 | -1,670 | -2,450 |
| Net Income Continuous | -2,459 | -2,577 | -1,931 | -1,672 | -2,569 |
| Net Income | $-2,459 | $-2,577 | $-1,931 | $-1,672 | $-2,569 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.03 | -0.03 | -0.06 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.03 | -0.03 | -0.06 |
| EPS Diluted Total Ops | -0.05 | -0.05 | -0.03 | -0.03 | -0.06 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.03 | -0.03 | -0.06 |
| EBITDA(a) | $-1,843 | $-1,837 | $-1,430 | $-1,370 | $-491 |